tyrosyltyrosine has been researched along with Morbid Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almorza-Gomar, D; Camacho-Ramírez, A; Díaz-Gómez, A; Gracia-Romero, M; Pérez-Arana, GM; Prada-Oliveira, JA; Ribelles-García, A | 1 |
| Barreto, SG; Chapman, I; Chisholm, J; Kow, L; Soenen, S | 1 |
1 review(s) available for tyrosyltyrosine and Morbid Obesity
| Article | Year |
|---|---|
Does the ileal brake mechanism contribute to sustained weight loss after bariatric surgery?
Topics: Appetite; Bariatric Surgery; Bone Density; Dipeptides; Gastrointestinal Hormones; Humans; Ileum; Obesity, Morbid; Weight Loss | 2018 |
1 other study(ies) available for tyrosyltyrosine and Morbid Obesity
| Article | Year |
|---|---|
Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Gastric Bypass; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Hypertrophy; Insulins; Obesity, Morbid; Rats | 2022 |